Recent studies on major depression have used Gfap in human postmortem experiments and animal models of depression to measure astrocyte cell number; multiple reports have reported decreased astrocyte cell density in these conditions based on Gfap protein measurements (e.g., Rajkowska et al., 1999; Miguel-Hidalgo et al., 2000). Here, GFAP is linked to depressive disorder.